|
⚲
|
| Keyboard |
| Scott Glenn | |
|---|---|
| Firm | |
| Address | 9410 Carroll Park Dr San Diego, CA 92121 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Evida Biosciences Inc | 021-526564 | Director | 42.0 M of 42.0 M |
||
| Mirador Therapeutics Inc | 021-509566 | Director | 333.0 M of 333.0 M |
||
| Mirador Therapeutics Inc | 021-509562 | Director | 80.0 M of 80.0 M |
||
| Rebalance Health Inc | 021-490828 | Executive Officer | 7.4 M of 10.0 M |
||
| Rebalance Health Inc | 021-445556 | Executive Officer | 7.6 M of 10.0 M |
||
| GLO Pharma Inc | 021-413342 | Director | 53.0 M of 53.0 M |
||
| Rebalance Health Inc | 021-408803 | Director | 6.7 M of 6.7 M |
||
| GLO Pharma Inc | 021-381523 | Executive Officer | 6.8 M of 6.8 M |
||
| GLO Pharma Inc | 021-381518 | Executive Officer | 0.5 M of 0.5 M |
||
| Prometheus Biosciences Inc | 021-344258 | Executive Officer | 48.1 M of 60.0 M |
||
| Precision IBD Inc | 021-326766 | Executive Officer | 10.1 M of 20.0 M |
||
| Oncternal Therapeutics Inc | 021-326302 | Director | 17.0 M of 24.0 M |
||
| Velosbio Inc | 021-318040 | Director | 6.5 M of 6.5 M |
||
| Alastin Skincare Inc | 021-308408 | Director | 5.8 M of 7.0 M |
||
| Velosbio Inc | 021-306354 | Director | 7.7 M of 7.7 M |
||
| Precision IBD Inc | 021-296321 | Executive Officer | 3.7 M of 10.0 M |
||
| Oncternal Therapeutics Inc | 021-295508 | Director | 6.9 M of 11.3 M |
||
| Oncternal Therapeutics Inc | 021-266615 | Director | 0.1 M of 3.3 M |
||
| Oncternal Therapeutics Inc | 021-264575 | Director | 13.1 M of 13.1 M |
||
| Alastin Skincare Inc | 021-245425 | Director | 14.7 M of 15.0 M |
||
| Oncternal Therapeutics Inc | 021-245323 | Director | 17.9 M of 23.5 M |
||
| Alastin Skincare Inc | 021-237977 | Executive Officer | 1.0 M of 1.0 M |
||
| Tokalas Inc | 021-212910 | Executive Officer | 3.1 M of 3.3 M |
||
| Kalyra Pharmaceuticals Inc | 021-201695 | Director | 6.2 M of 7.0 M |
||
| Exagen Diagnostics Inc | 021-168978 | Director | 1.0 M of 1.0 M |
||
| Exagen Diagnostics Inc | 021-166420 | Executive Officer | 4.9 M of 6.5 M |
||
| Exagen Diagnostics Inc | 021-162022 | Executive Officer | 4.9 M of 5.8 M |
||
| Selexagen Therapeutics Inc | 021-151616 | Director | 0.6 M of 0.6 M |
||
| Exagen Diagnostics Inc | 021-149543 | Executive Officer | 5.4 M of 5.4 M |
||
| Planet Biopharmaceuticals Inc | 021-147909 | Director | 1.5 M of 1.7 M |
||
| Evoke Pharma Inc | 021-144215 | Director | 6.0 M of 6.0 M |
||